Evaluation of serum changes in inflammatory agents in patients with endometrioma after ethanol injection by residual method

Phase 2

Recruiting

• Conditions: Endometriosis of ovary.; Endometriosis of ovary; N80.1

• Registration Number: IRCT20130115012146N9
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 25

Inclusion Criteria

Women with symptomatic endometrial cysts above 3 cm
Women with asymptomatic endometrial cysts above 3 cm
Willingness to cooperate

Exclusion Criteria

Patients with a history of malignancy
Patients with a history of inflammatory and autoimmune diseases
Patients with a history of corticosteroid and immunosuppressive drugs
Patients with a history of taking non-steroidal anti-inflammatory drugs for the past 7 days
Patients with abnormal CEA-125 levels
Patients with cysts with a volume of more than 150 ml

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of serum interleukin (IL) levels 1ß. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Blood test.;Evaluation of serum IL-6 levels. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Blood test.;Evaluation of serum IL-8 levels. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Blood test.;Evaluation of serum AMH levels. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Blood test.

Secondary Outcome Measures

Name	Time	Method
Recurrence of the cyst. Timepoint: Before the intervention and three months after the end of the intervention. Method of measurement: Vaginal ultrasound.